Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

Rhea-AI Summary

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company focused on developing genetic medicines for rare and prevalent diseases, has announced its participation in the 2024 Cantor Global Healthcare Conference. Geoff McDonough, M.D., the company's president and CEO, will engage in a fireside chat on Thursday, September 19, 2024, at 10:20 a.m. ET in New York.

Investors and interested parties can access a live webcast of the presentation through the investor section of Generation Bio's website at investors.generationbio.com. For those unable to attend the live event, a replay will be available on the same platform for 30 days following the conference.

CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 10:20 a.m. ET in New York.

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.com. A replay will be available there for 30 days following the event.

About Generation Bio   

Generation Bio is innovating non-viral genetic medicines to provide durable and redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). With these platforms, Generation Bio aims to develop the next wave of non-viral genetic medicines to support its mission to extend the reach of genetic medicine to more people living with more diseases, around the world.

For more information, please visit www.generationbio.com.

Investors and Media Contact  
Maren Killackey  
Generation Bio  
mkillackey@generationbio.com
857-371-4638

FAQ

When is Generation Bio (GBIO) presenting at the 2024 Cantor Global Healthcare Conference?

Generation Bio (GBIO) is presenting at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 10:20 a.m. ET in New York.

Who will represent Generation Bio (GBIO) at the 2024 Cantor Global Healthcare Conference?

Geoff McDonough, M.D., president and chief executive officer of Generation Bio (GBIO), will represent the company in a fireside chat at the conference.

How can I watch Generation Bio's (GBIO) presentation at the 2024 Cantor Global Healthcare Conference?

A live webcast of Generation Bio's (GBIO) presentation will be available on the investor section of the company's website at investors.generationbio.com.

For how long will the replay of Generation Bio's (GBIO) presentation be available?

A replay of Generation Bio's (GBIO) presentation will be available on the company's investor website for 30 days following the event.

What is the focus of Generation Bio's (GBIO) research and development?

Generation Bio (GBIO) is a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases.